Clinical Trials Logo

Neurotransmitter Agents clinical trials

View clinical trials related to Neurotransmitter Agents.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT05615948 Active, not recruiting - Clinical trials for Major Depressive Disorder

Oral Aspirin + Ketamine as Adjunct to Oral Antidepressant Therapy for Depression

Start date: December 6, 2022
Phase: Phase 4
Study type: Interventional

The purpose of this study is to assess the effects of simultaneous administration of oral aspirin and oral ketamine as a therapeutic for those with Treatment Resistant Depression.